Pegasus

Miniaturized Biosensor Developer Receives Funding

March 15, 2017
Miniaturized Biosensor Developer Receives Funding

The Florida Institute for the Commercialization of Public Research announced that Aviana Molecular Technologies, LLC, an Orlando-based point of care (POC) diagnostics company, received follow-on second round financing after reaching development milestones since its initial funding.

According to the Florida Institute, Aviana is developing miniaturized biosensors capable of attaching to a smartphone/smart device through Bluetooth or other wireless connections. Aviana’s diagnostic system is a user-friendly, potentially highly sensitive diagnostic platform that can accurately, within 10-20 minutes, detect a target infectious disease, biomarkers, or proteins in both clinical (human and animal) and scientific research settings.

“Our mission is to provide highly sensitive and specific diagnostic capability to anyone with a smart device: physician, medical technologist, patient, or public health worker while connecting seamlessly (with adequate protections) to the internet,” said Vanaja V. Ragavan, M.D., Aviana’s president and CEO, in the press release.

Voice your opinion!

To join the conversation, and become an exclusive member of Supply Chain Connect, create an account today!